The effect of fish-oil supplementation on maternal and neonatal outcomes: a triple blind randomized controlled trial
The effect of fish-oil supplementation on maternal and neonatal outcomes: a triple blind randomized controlled trial
Azizeh Farshbaf-Khalili1 Alireza Ostadrahimi2,2 Sakineh Mohammad-Alizadeh3 Jamileh Malakouti44 Nayyer Jafarilar-Agdam5 Elham Shahrisa66
1) 1- Student of PhD by research, Health Services Management Research Center, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences Tabriz, Iran. Corresponding Author. E-mail:
2) 2- Professor, Nutrition Research Center, Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3) 3- Associate professor, Department of Midwifery, Faculty of Nursing and Midwifery, Research Center of Social Determinants of Health, Tabriz University of Medical Sciences, Tabriz, IR Iran
4) 4- Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, IR Iran.
5) 5- BSc in midwifery, Health Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
6) 5- BSc in midwifery, Health Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
IOI Code
:
XYGD-BCGZC
Publication :
The 5th International conference of Sciences and Engineering(5icesconf.com)
Abstract :
Objective: to evaluate the effect of fish oil supplementation on pregnancy outcomes in mother and newborn.
Method: This randomized, triple-blinded placebo-controlled trial conducted on 150 pregnant women aged 18-35 from Feburary 2014 to April 2015 in Tabriz, Iran.Participants assigned to receive either 1000 mg fish oil supplements containing 180 mg eicosapentaenoic acid and 120 mg docosahexanoic acid from the week 20 of gestation to birth. Primary outcome measure was birth weight. Gestational duration, preterm labor, low birth weight (LBW), length, and head circumference were also examined. The statistical analysis was intent-to-treat.
Results: Demographic characteristics were similar in both groups (P>0.05). The mean (SD) birth weight in the fish oil and placebo groups were 3256g (362) and 3172g (447), respectively (adjusted MD = 84.1g; [95% CI -24.8, 193.2]). Five (7.6%) neonates in the placebo group and no one in the fish oil group were born with LBW (p = 0.02). The rate of preterm labor was lower in the fish oil group (adjusted OR=0.74; [95% CI 0.16, 3.42]). However, there were no statistically significant differences in the maternal outcomes (P>0.05) with exception of the proportion of maternal serum DHA fatty acid at 35-37 weeks (P<0.001)
Conclusion: Low dose fish oil supplementation had no significant effect on birth weight but reduced the frequency of low birth weight. The observed reduction in low birth weight frequency need to be confirmed in future larger investigations using different doses of omega-3.
Keywords : oil supplemention omega 3 pregnancy mothers neonates